ACCENDRA HEALTH INC/VA/ - Common Stock (ACH)

CUSIP: 690732102

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
76,424,795
Total 13F shares
74,911,735
Share change
+728,789
Total reported value
$681,592,001
Put/Call ratio
112%
Price per share
$9.10
Number of holders
231
Value change
+$6,808,279
Number of buys
121
Number of sells
121

Security key

690732102

Report period

Q2 2025

Institutions

231

Top holders

10

Top shareholders of ACH - ACCENDRA HEALTH INC/VA/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F 13D/G
Company
3.5%
from 13D/G
2,718,754
$24,550,350 31 Mar 2025
Michael Wayne Lowry
3/4/5
SVP, Corporate Controller
0.16%
121,921
$853,447 15 May 2025
Jennifer A. Stone
3/4/5
EVP, CHRO
0.14%
110,327
$700,576 03 Jun 2025
Snehashish Sarkar
3/4/5
Chief Information Officer
0.14%
108,586
$760,102 15 May 2025
Robert J. Henkel
3/4/5
Director
0.1%
77,412
$538,013 15 May 2025
Rita Johnson-Mills
3/4/5
Director
0.07%
54,125
$376,168 15 May 2025
Carissa Rollins
3/4/5
Director
0.07%
53,902
$374,618 15 May 2025
BlackRock, Inc.
13F
Company
15%
11,510,044
$103,935,697 31 Mar 2025
13F
Coliseum Capital Management, LLC
13F
Company
14%
10,624,599
$95,940,129 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
12%
9,156,759
$82,685,533 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.7%
4,387,191
$39,613,219 31 Mar 2025
13F
STATE STREET CORP
13F
Company
4.1%
3,134,287
$28,302,612 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.6%
2,752,960
$24,859,229 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
1,758,364
$15,881,569 31 Mar 2025
13F
Invesco Ltd.
13F
Company
2.2%
1,716,895
$15,503,562 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.7%
1,310,844
$11,836,929 31 Mar 2025
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
1.6%
1,203,397
$10,866,675 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.3%
964,628
$8,710,592 31 Mar 2025
13F
Dana Investment Advisors, Inc.
13F
Company
1.3%
956,203
$8,634,513 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.2%
908,850
$8,206,916 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.1%
812,233
$7,334,464 31 Mar 2025
13F
TOWLE & CO
13F
Company
1%
797,366
$7,200,215 31 Mar 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.92%
703,050
$6,348,542 31 Mar 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.83%
634,914
$5,733,273 31 Mar 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.81%
619,234
$5,591,683 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.75%
576,799
$5,208,495 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.73%
559,465
$5,051,972 31 Mar 2025
13F
Freestone Grove Partners LP
13F
Company
0.71%
541,967
$4,893,962 31 Mar 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.68%
523,464
$4,726,883 31 Mar 2025
13F
Saba Capital Management, L.P.
13F
Company
0.62%
475,758
$4,296,095 31 Mar 2025
13F
UBS Group AG
13F
Company
0.6%
456,837
$4,125,238 31 Mar 2025
13F
FEDERATED HERMES, INC.
13F
Company
0.56%
428,598
$3,870,240 31 Mar 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.54%
413,280
$3,731,918 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.54%
412,987
$3,729,273 31 Mar 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.54%
409,543
$3,698,173 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.51%
387,245
$3,496,822 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.5%
383,183
$3,460,142 31 Mar 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.48%
368,459
$3,327,186 31 Mar 2025
13F
Empowered Funds, LLC
13F
Company
0.48%
365,634
$3,301,675 31 Mar 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.47%
357,475
$3,227,999 31 Mar 2025
13F
ALGERT GLOBAL LLC
13F
Company
0.43%
329,227
$2,973,000 31 Mar 2025
13F
Cubist Systematic Strategies, LLC
13F
Company
0.43%
327,182
$2,954,453 31 Mar 2025
13F
GABELLI FUNDS LLC
13F
Company
0.43%
326,000
$2,943,780 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.41%
311,537
$2,813,179 31 Mar 2025
13F
LHM, INC.
13F
Company
0.38%
292,942
$2,645,266 31 Mar 2025
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.38%
289,400
$2,613,282 31 Mar 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
0.37%
282,310
$2,549,259 31 Mar 2025
13F
Advisors Preferred, LLC
13F
Company
0.36%
271,470
$2,454,089 31 Mar 2025
13F
Walleye Capital LLC
13F
Company
0.35%
266,248
$2,404,219 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.34%
262,720
$2,372,361 31 Mar 2025
13F

Institutional Holders of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) as of Q2 2025

As of 30 Jun 2025, ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) was held by 231 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,911,735 shares. The largest 10 holders included Coliseum Capital Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, PARADIGM CAPITAL MANAGEMENT INC/NY, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, and D. E. Shaw & Co., Inc.. This page lists 230 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
242
Q2 2025 holders
231
Holder diff
-11
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .